Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Commentary

Thiazolidinediones: Do harms outweigh benefits?

Lorraine L. Lipscombe
CMAJ January 06, 2009 180 (1) 16-17; DOI: https://doi.org/10.1503/cmaj.081713
Lorraine L. Lipscombe MD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Article Information

vol. 180 no. 1 16-17
DOI 
https://doi.org/10.1503/cmaj.081713
PubMed 
19073650
History 
  • Published online January 5, 2009.

Article Versions

  • Latest version (December 10, 2008 - 04:26).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2009 Canadian Medical Association

Author Information

  1. Lorraine L. Lipscombe MD MSc
  1. Dr. Lipscombe is with the Institute for Clinical Evaluative Sciences, the Department of Medicine, University of Toronto, and Women's College Hospital, Toronto, Ont.
  1. Correspondence to:
    Dr. Lorraine Lipscombe, Institute for Clinical Evaluative Sciences, 2075 Bayview Ave., Toronto ON M4N 3M5; fax 416 323-6534; Lorraine.Lipscombe{at}ices.on.ca

Statistics from Altmetric.com

Usage statistics: January 2009 to January 2023

AbstractFullPdf
Jan 20090909500
Feb 20090172224
Mar 2009010993
Apr 200909567
May 200907548
Jun 200904947
Jul 200905231
Aug 200903925
Sep 200904711
Oct 200905530
Nov 200904022
Dec 200904218
Jan 201003524
Feb 201004022
Mar 201004419
Apr 201003519
May 201003518
Jun 201002712
Jul 201003014
Aug 201001316
Sep 201003119
Oct 201003225
Nov 201002316
Dec 201001911
Jan 201102622
Feb 201102318
Mar 201103914
Apr 201102513
May 201101911
Jun 201102215
Jul 201101317
Aug 201101729
Sep 201102032
Oct 201103826
Nov 201103418
Dec 201103828
Jan 201203818
Feb 201203524
Mar 201203824
Apr 201202823
May 201203829
Jun 201204919
Jul 201204927
Aug 201202527
Sep 201203323
Oct 201204325
Nov 201204624
Dec 20120379
Jan 201305010
Feb 201303110
Mar 20130527
Apr 201304416
May 201302810
Jun 20130143
Jul 20130134
Aug 20130256
Sep 20130215
Oct 20130124
Nov 20130124
Dec 20130142
Jan 2014074
Feb 2014072
Mar 2014083
Apr 2014071
May 2014070
Jun 20140102
Jul 20140193
Aug 201402010
Sep 20140154
Oct 20140164
Nov 20140208
Dec 20140113
Jan 20150125
Feb 2015083
Mar 201501719
Apr 2015062
May 20150152
Jun 20150118
Jul 2015090
Aug 20150275
Sep 20150117
Oct 20150193
Nov 20150296
Dec 20150276
Jan 201604311
Feb 20160256
Mar 20160133
Apr 20160122
May 2016067
Jun 20160183
Jul 20160214
Aug 20160233
Sep 20160234
Oct 201603311
Nov 20160387
Dec 20160181
Jan 20170162
Feb 20170156
Mar 20170171
Apr 20170192
May 20170302
Jun 20170182
Jul 20170140
Aug 2017092
Sep 201701415
Oct 20170150
Nov 20170154
Dec 20170122
Jan 20180225
Feb 20180172
Mar 20180155
Apr 20180196
May 20180145
Jun 20180256
Jul 2018092
Aug 20180108
Sep 2018084
Oct 2018084
Nov 20180168
Dec 20180117
Jan 20190113
Feb 20190169
Mar 201901811
Apr 20190310
May 2019083
Jun 2019097
Jul 20190168
Aug 2019074
Sep 20190163
Oct 20190184
Nov 20190106
Dec 2019066
Jan 20200910
Feb 2020054
Mar 2020033
Apr 2020051
May 20200406
Jun 20200322
Jul 20200128
Aug 20200106
Sep 2020028
Oct 20200247
Nov 202001811
Dec 202001715
Jan 20210119
Feb 20210119
Mar 20210418
Apr 202103010
May 20210129
Jun 20210206
Jul 202102422
Aug 202103513
Sep 2021011014
Oct 202102325
Nov 202102627
Dec 20210155
Jan 2022073
Feb 2022064
Mar 2022097
Apr 202202510
May 20220329
Jun 202201611
Jul 202201210
Aug 202201515
Sep 202201814
Oct 202201814
Nov 202201610
Dec 202202413
Jan 20230427

Cited By...

  • 15 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 180 (1)
CMAJ
Vol. 180, Issue 1
6 Jan 2009
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Thiazolidinediones: Do harms outweigh benefits?
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Thiazolidinediones: Do harms outweigh benefits?
Lorraine L. Lipscombe
CMAJ Jan 2009, 180 (1) 16-17; DOI: 10.1503/cmaj.081713

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Thiazolidinediones: Do harms outweigh benefits?
Lorraine L. Lipscombe
CMAJ Jan 2009, 180 (1) 16-17; DOI: 10.1503/cmaj.081713
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Responses
  • Metrics
  • PDF

Related Articles

  • Highlights
  • Dans ce numéro
  • Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis
  • PubMed
  • Google Scholar

Cited By...

  • Adiponectin: An Indispensable Molecule in Rosiglitazone Cardioprotection Following Myocardial Infarction
  • Complementary and alternative medicine for the treatment of type 2 diabetes
  • Thiazolidinedione use and the risk of fractures
  • Google Scholar

More in this TOC Section

  • Antiracism as a foundational competency: reimagining CanMEDS through an antiracist lens
  • Keeping the front door open: ensuring access to primary care for all in Canada
  • Improving post-tuberculosis care in Canada
Show more Commentary

Similar Articles

Collections

  • Topics
    • Diabetes
    • Drugs: adverse reactions

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire